Voyager Therapeutics (VYGR) Competitors $5.75 +0.06 (+1.05%) (As of 12/20/2024 05:17 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends VYGR vs. OCUL, MESO, TVTX, NTLA, PRAX, ARVN, DAWN, ARDX, SYRE, and SPRYShould you be buying Voyager Therapeutics stock or one of its competitors? The main competitors of Voyager Therapeutics include Ocular Therapeutix (OCUL), Mesoblast (MESO), Travere Therapeutics (TVTX), Intellia Therapeutics (NTLA), Praxis Precision Medicines (PRAX), Arvinas (ARVN), Day One Biopharmaceuticals (DAWN), Ardelyx (ARDX), Spyre Therapeutics (SYRE), and ARS Pharmaceuticals (SPRY). These companies are all part of the "pharmaceutical products" industry. Voyager Therapeutics vs. Ocular Therapeutix Mesoblast Travere Therapeutics Intellia Therapeutics Praxis Precision Medicines Arvinas Day One Biopharmaceuticals Ardelyx Spyre Therapeutics ARS Pharmaceuticals Voyager Therapeutics (NASDAQ:VYGR) and Ocular Therapeutix (NASDAQ:OCUL) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, community ranking, risk, media sentiment and institutional ownership. Do analysts rate VYGR or OCUL? Voyager Therapeutics currently has a consensus target price of $17.00, suggesting a potential upside of 195.65%. Ocular Therapeutix has a consensus target price of $16.71, suggesting a potential upside of 96.64%. Given Voyager Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Voyager Therapeutics is more favorable than Ocular Therapeutix.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Voyager Therapeutics 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 3.11Ocular Therapeutix 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.86 Do institutionals & insiders believe in VYGR or OCUL? 48.0% of Voyager Therapeutics shares are owned by institutional investors. Comparatively, 59.2% of Ocular Therapeutix shares are owned by institutional investors. 4.5% of Voyager Therapeutics shares are owned by company insiders. Comparatively, 3.5% of Ocular Therapeutix shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has more volatility and risk, VYGR or OCUL? Voyager Therapeutics has a beta of 0.9, meaning that its stock price is 10% less volatile than the S&P 500. Comparatively, Ocular Therapeutix has a beta of 1.19, meaning that its stock price is 19% more volatile than the S&P 500. Does the MarketBeat Community believe in VYGR or OCUL? Ocular Therapeutix received 45 more outperform votes than Voyager Therapeutics when rated by MarketBeat users. Likewise, 70.14% of users gave Ocular Therapeutix an outperform vote while only 67.59% of users gave Voyager Therapeutics an outperform vote. CompanyUnderperformOutperformVoyager TherapeuticsOutperform Votes39267.59% Underperform Votes18832.41% Ocular TherapeutixOutperform Votes43770.14% Underperform Votes18629.86% Is VYGR or OCUL more profitable? Voyager Therapeutics has a net margin of 15.80% compared to Ocular Therapeutix's net margin of -283.74%. Voyager Therapeutics' return on equity of 8.33% beat Ocular Therapeutix's return on equity.Company Net Margins Return on Equity Return on Assets Voyager Therapeutics15.80% 8.33% 6.15% Ocular Therapeutix -283.74%-45.18%-30.87% Does the media favor VYGR or OCUL? In the previous week, Voyager Therapeutics had 1 more articles in the media than Ocular Therapeutix. MarketBeat recorded 3 mentions for Voyager Therapeutics and 2 mentions for Ocular Therapeutix. Ocular Therapeutix's average media sentiment score of 0.72 beat Voyager Therapeutics' score of 0.50 indicating that Ocular Therapeutix is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Voyager Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Ocular Therapeutix 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Which has preferable valuation & earnings, VYGR or OCUL? Voyager Therapeutics has higher revenue and earnings than Ocular Therapeutix. Ocular Therapeutix is trading at a lower price-to-earnings ratio than Voyager Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVoyager Therapeutics$163.78M1.92$132.33M$0.718.10Ocular Therapeutix$61.44M21.75-$80.74M-$1.32-6.44 SummaryVoyager Therapeutics beats Ocular Therapeutix on 13 of the 19 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Get Voyager Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VYGR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VYGR vs. The Competition Export to ExcelMetricVoyager TherapeuticsBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$314.10M$2.94B$5.12B$9.07BDividend YieldN/A1.90%4.91%4.22%P/E Ratio8.1046.7391.3417.19Price / Sales1.92411.851,117.70116.80Price / Cash2.07182.1042.6437.86Price / Book1.073.894.794.78Net Income$132.33M-$42.21M$120.07M$225.60M7 Day Performance-8.29%-2.14%-1.90%-1.23%1 Month Performance5.89%4.21%11.45%3.37%1 Year Performance-29.45%18.40%30.63%16.58% Voyager Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VYGRVoyager Therapeutics4.6047 of 5 stars$5.75+1.1%$17.00+195.7%-27.6%$314.10M$163.78M8.10100OCULOcular Therapeutix3.6461 of 5 stars$9.03+3.9%$16.71+85.1%+116.8%$1.42B$58.44M0.00267Positive NewsMESOMesoblast1.0466 of 5 stars$12.16+3.4%$11.50-5.4%+590.1%$1.39B$5.90M0.0080Analyst ForecastOptions VolumeNews CoverageGap DownTVTXTravere Therapeutics2.7815 of 5 stars$17.65+1.9%$22.62+28.1%+106.0%$1.38B$145.24M-3.81460Positive NewsNTLAIntellia Therapeutics4.1284 of 5 stars$13.50+4.7%$54.94+306.9%-58.9%$1.37B$36.28M-2.37600PRAXPraxis Precision Medicines2.4059 of 5 stars$71.98+2.6%$146.33+103.3%+323.0%$1.34B$2.45M-7.06110Gap DownHigh Trading VolumeARVNArvinas2.0323 of 5 stars$19.35-0.8%$63.50+228.2%-49.3%$1.33B$78.50M-4.18445DAWNDay One Biopharmaceuticals1.6299 of 5 stars$12.74-0.1%$35.71+180.3%-7.7%$1.28B$101.95M-12.3860Positive NewsARDXArdelyx3.6852 of 5 stars$5.39+3.3%$10.42+93.3%-18.9%$1.28B$251.85M-17.80267SYRESpyre Therapeutics1.77 of 5 stars$24.65+2.2%$51.50+108.9%+53.4%$1.27B$890,000.00-3.23100SPRYARS Pharmaceuticals2.9441 of 5 stars$12.27+3.1%$24.00+95.6%+121.8%$1.19B$30,000.00-23.3390Insider TradeNews Coverage Related Companies and Tools Related Companies Ocular Therapeutix Alternatives Mesoblast Alternatives Travere Therapeutics Alternatives Intellia Therapeutics Alternatives Praxis Precision Medicines Alternatives Arvinas Alternatives Day One Biopharmaceuticals Alternatives Ardelyx Alternatives Spyre Therapeutics Alternatives ARS Pharmaceuticals Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:VYGR) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Voyager Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Voyager Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VYGR Stock Alerts